Founder CEO
Molgenium
Düsseldorf, Nordrhein-Westfalen, Germany
Dr. Mohamad Toutounji is an independent pharmaceutical consultant with over six years of
experience in CMC, QC, and regulatory affairs. He specializes in mRNA therapies, GMP compliance,
and analytical method development. His work supports global regulatory submissions and the
development of biologics, cell and gene therapies, and mRNA-based drug products.
Disclosure information not submitted.
Shaping the Future of mRNA Vaccines: A Regulatory Perspective
Friday, May 16, 2025
10:30 - 11:30 CEST